Your browser doesn't support javascript.
loading
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.
Harding, Simon D; Armstrong, Jane F; Faccenda, Elena; Southan, Christopher; Alexander, Stephen P H; Davenport, Anthony P; Pawson, Adam J; Spedding, Michael; Davies, Jamie A.
Afiliación
  • Harding SD; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Armstrong JF; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Faccenda E; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Southan C; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Alexander SPH; School of Life Sciences, University of Nottingham Medical School, Nottingham NG7 2UH, UK.
  • Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Pawson AJ; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Spedding M; Spedding Research Solutions SAS, Le Vésinet 78110, France.
  • Davies JA; Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
Nucleic Acids Res ; 50(D1): D1282-D1294, 2022 01 07.
Article en En | MEDLINE | ID: mdl-34718737
ABSTRACT
The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb; www.guidetopharmacology.org) is an open-access, expert-curated database of molecular interactions between ligands and their targets. We describe expansion in content over nine database releases made during the last two years, which has focussed on three main areas of infection. The COVID-19 pandemic continues to have a major impact on health worldwide. GtoPdb has sought to support the wider research community to understand the pharmacology of emerging drug targets for SARS-CoV-2 as well as potential targets in the host to block viral entry and reduce the adverse effects of infection in patients with COVID-19. We describe how the database rapidly evolved to include a new family of Coronavirus proteins. Malaria remains a global threat to half the population of the world. Our database content continues to be enhanced through our collaboration with Medicines for Malaria Venture (MMV) on the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY (www.guidetomalariapharmacology.org). Antibiotic resistance is also a growing threat to global health. In response, we have extended our coverage of antibacterials in partnership with AntibioticDB.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD Problema de salud: 2_cobertura_universal / 2_enfermedades_transmissibles / 3_malaria / 3_neglected_diseases / 4_pneumonia Asunto principal: Antivirales / Tratamiento Farmacológico de COVID-19 / Antibacterianos / Antimaláricos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Nucleic Acids Res Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD Problema de salud: 2_cobertura_universal / 2_enfermedades_transmissibles / 3_malaria / 3_neglected_diseases / 4_pneumonia Asunto principal: Antivirales / Tratamiento Farmacológico de COVID-19 / Antibacterianos / Antimaláricos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Nucleic Acids Res Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
...